Searchable abstracts of presentations at key conferences in endocrinology

ea0029p106 | Adrenal cortex | ICEECE2012

Comparison of four immunoassays for measurement of cortisol levels

Gruson D. , Lepoutre T. , Galanti L.

Background: Measurement of serum cortisol levels can be useful in the diagnosis of conditions of both adrenal insufficiency and excess. Several methods are available for the measurement of the cortisol levels and immunoassays are commonly used in routine laboratories. The aim of our study was therefore to compare four different automated immunoassays for measurement of cortisol in serum.Methods: Serum samples of seventy two healthy volunteers were used f...

ea0029p280 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

The role of testosterone activation of liver X receptor in a human macrophage cell line and its implications for the treatment of type 2 diabetes and atherosclerosis

Kilby E. , Akhtar S. , Jones T.

Testosterone deficiency is common in men with type 2 diabetes (T2D) and cardiovascular diseases (CVD), such as atherosclerosis. Previous studies have shown that testosterone replacement improves several cardiovascular risk factors including insulin resistance, glycaemic control, cholesterol and inflammation. The mechanisms by which testosterone mediates these effects are unknown. LXR, a nuclear receptor also regulates these cardiovascular risk factors and the atheroprotective ...

ea0029p347 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Hyponatraemia assessment and outcomes in acute medically ill patients

Hughes A. , Taha O. , Tetlow T. , Jude E.

Hyponatraemia is the most common electrolyte abnormality, encountered in up to 30% of inpatients. Inappropriate management can have serious implications for patients; including demyelinating disease, coma, and death.Methods: Patients (n=100) admitted to the medical admission unit of a district general hospital with a serum sodium (Na) <130 were selected for the study. All details including patient demographics, blood biochemistry, date of admi...

ea0029p403 | Clinical case reports - Thyroid/Others | ICEECE2012

A rare case of vanishing fetal goiter and role of colour doppler ultrasound in the diagnosis

Panchani R. , Saini A. , Varma T. , Tripathi S.

Introduction: Fetal goiter is a rare condition. The incidence of goitrous hypothyroidism is 1/30 000–50 000 live births. We describe a case of antenatal fetal goiter that vanished upon delivery and was not detected in the newborn. The case report is followed by a discussion wherein we review the literature on thyroid problems in pregnancy and management of fetal goiter.Case report: A 27-year-old known hypothyroid woman with bichorial biamniotic preg...

ea0029p491 | Developmental endocrinology | ICEECE2012

DHEA attenuated mature adipocyte proliferation

Mori I. , Kajita K. , Fujioka K. , Hanamoto T. , Ikeda T. , Okada H. , Usui T. , Takahashi N. , Taguchi K. , Kitada Y. , Uno Y. , Morita H. , Ishizuka T.

Back ground: Numerous researches indicate that DHEA administration decreases fat mass in human and rodent. We evaluated the effects of DHEA treatment on adiposity. Male Otsuka Long evans fatty (OLETF) rats, hereditary obese type 2 diabetic animals derived from long evans tokushima (LETO) rats. These rats were fed with or without (control) 0.4% DHEA containing food for 52 weeks. Telomere length as a marker of whole cell division in adipose tissue were assessed. Genomic DNA isol...

ea0029p665 | Diabetes | ICEECE2012

Relationship Between HbA1c and Asymptomatic Coronary Artery Disease in Type 2 Diabetes Patients

Dundua M. , Akhobadze T. , Kurashvili R. , Kopaleishvili A.

Background: Patients with type 2 diabetes mellitus (T2DM) have elevated risk of coronary artery disease (CAD) development. In this population CAD often proceedsasymptomatically, especially if cardiac autonomic neuropathy (CAN) is present. Our aim was to assess relation between glycemia control and asymptomatic CAD inT2DM pts. Materials and methods: Participants were 160 T2DM patients without documented CAD divided into four groups (Gr.) according to HbA1c levels: Gr. 1 -HbA1c6...

ea0029p687 | Diabetes | ICEECE2012

DPP-4 inhibitor vildagliptin reduces urinary albumin excretion in type 2 diabetic patients with microalbuminuria

Watanabe M. , Furuya F. , Kobayashi T.

Introduction: A potent and selective DPP-4 inhibitor improves islet function by enhancing α- and β-cell responsiveness to glucose in the diabetic patients. Renal impairment is a common complication of type 2 diabetes mellitus (T2DM). Vildagliptin is used to treat T2DM as monotherapy or in combination with other antidiabetic drugs, since that it efficiently decreases glycated hemoglobin (HbA1c) values. Additionally, vildagliptin has been shown to be safe in patients w...

ea0029p757 | Endocrine Disruptors | ICEECE2012

Proliferative and apoptotic effects of bisphenol A and its combination with estradiol in human breast carcinoma cells

Havranek T. , Macho L. , Fickova M.

Bisphenol A (BPA) is an endocrine disruptor (ED) used as plasticiser present in plastic products of daily use. The leakage of BPA monomer into food, drinks represents the ubiquitous exposure to the general population. BPA stimulatory effect on breast cancer cells growth in vitro and increased incidence of hormone dependent malignancies suspected BPA from carcinogenic effect.The aim of this study was to investigate the effects of BPA alone and in t...

ea0029p812 | Endocrine tumours and neoplasia | ICEECE2012

Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?

Sane T. , Schalin-Jantti C. , Raade M.

Introduction: Pheochromocytomas are characterized by a high attenuation value on unenhanced computed tomography (CT). It is not known whether pheochromocytoma can be outruled as a cause of adrenal incidentalomas based on unenhanced attenuation values only. We evaluated the outcome of routine biochemical screening for pheochromocytoma in a series of patients with adrenal incidentalomas in relationship to the unenhanced attenuation values on CT.Design and ...

ea0029p849 | Endocrine tumours and neoplasia | ICEECE2012

Gene expression profile of LNCaP human prostate cancer cells after treatment with an antagonist of growth hormone-releasing hormone

Rekasi Z. , Czompoly T. , Zarandi M. , Schally A.

Antagonists of growth hormone-releasing hormone (GHRH-ant) may exert their antiproliferative effects directly on cancer cells, which are mediated by the tumoral GHRH receptors identified by us. Furthermore we showed that GHRH-ant are able to induce apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway. However, the molecular features involved in the antiproliferative effect of GHRH-ant have not yet been elucidated. To study this, gene expression profi...